Cantor Fitzgerald Maintains Overweight on Progyny, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James maintains an Overweight rating on Progyny (NASDAQ:PGNY) but lowers the price target from $48 to $37.
August 07, 2024 | 6:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cantor Fitzgerald maintains an Overweight rating on Progyny but lowers the price target from $48 to $37.
The lowered price target from $48 to $37 suggests a less optimistic outlook for Progyny's stock performance, which could lead to a short-term negative impact on the stock price despite the maintained Overweight rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100